
Eternity Protocol
Peptides, GLP-1, longevity. Explained.
Plain-language research on the new science of living longer. We read the studies so you don't have to.
24
Articles, plain language
4
Topics covered
17
Country communities
0
Hype words allowed
More worth reading.
All articles →GLP-1
GLP-1s Explained: Why 1 in 7 Americans Are Taking Them
GLP-1 agonists like semaglutide and tirzepatide are the most effective weight-loss drugs ever created. This guide explains how they work, what to expect, side effects, and who should use them.
Longevity
Why Everyone in Longevity Is Suddenly Stacking NAD+ With Peptides
NAD+ levels drop 50% by age 60. Longevity docs are restoring them with NMN and stacking targeted peptides in phased protocols, here's the science behind what actually works.
Peptides
The Peptides That Actually Reverse Skin Aging (According to the Data)
GHK-Cu, Matrixyl, and Argireline have clinical data showing they improve skin thickness, elasticity, and wrinkle depth. Here's what 18 months of research and testing taught me about peptides for skin.
GLP-1
The GLP-1 Side Effect Nobody's Tracking (But 2026 Research Says You Should)
New 2026 research shows GLP-1 users have 29% higher osteoporosis risk over five years. Here's what's happening to your bones, and what you should do about it.
What you'll learn
Four topics, decoded.
Each one is a body of science people are paying attention to. We translate it into plain language so you can decide what's worth your time and money.
01
Peptides
What they are, how they work in your body, which ones have human trial data, and which are still hype.
Read articles →
02
GLP-1
Tirzepatide, semaglutide, retatrutide. What the trials actually show, what the side effects are, who they're for.
Read articles →
03
Longevity
NAD+, senolytics, telomeres. The science of healthspan, what moves biomarkers, what doesn't.
Read articles →
04
Biohacking
Stacks and protocols people are running. What works, what's overhyped, what the data says.
Read articles →
Shop
Coming soon.
We're working on it. Be the first to know when it opens.
The standard
“If we don't know something, we say so. If a study is in rats not humans, we tell you. If a protocol is hype, we cut it.”
The Eternity standard
Stay close
Get one good article every Sunday.
Plain-language research on peptides, GLP-1, and longevity. No spam, no upsells, no hype. Unsubscribe in one click.
